Categories: HealthcareNews

LexisNexis Risk Solutions Launches Research-Ready Healthcare Data Blends to Expedite Research

Blended, patient-level datasets leveraging proprietary tokenization technology simplify data enrichment while adhering to privacy standards

ATLANTA, Jan. 29, 2025 /PRNewswire/ — LexisNexis® Risk Solutions, a leading provider of healthcare analytics and insights, today announced the launch of new research-ready, real-world datasets designed to accelerate research timelines, reduce costs and enable more equitable analyses. Using referential-based tokenization, the patient-level datasets are blended, expert determined and certified ensuring they are standardized and research ready. This process gives research teams a more simplified way to enrich their datasets or define a cohort of interest to support specific study objectives, including benchmarking with comparator cohorts. These datasets integrate into clinical research workflows, generating impactful real-world evidence to accelerate innovation and speed-to-market.

“By offering comprehensive, research-ready datasets that are standardized, expert determined and ready for immediate use, we’re enabling researchers to eliminate traditional data management challenges and accelerate their timeline to deliver actionable insights,” said Adam Mariano, president and general manager of healthcare, LexisNexis Risk Solutions. “We’re empowering research teams with a more efficient way to create more holistic and unbiased datasets, so they can uncover health disparities, develop personalized treatments, and ultimately improve patient outcomes across diverse populations.”

The new, expert determined data blends include two or more of the following datasets:

  • Care Delivery Insights: 
    • Healthcare utilization insights from de-identified open and closed medical, pharmacy and lab claims including diagnoses, comorbidities, service date, place of service, service codes and modifiers
    • Pharmacy/medication insights, including drug name, code, quantity and dosage
    • Financial insights, including details on the total cost of care
  • Social determinants of health (SDOH):
    • Factors such as transportation risks, financial challenges and proximity to care
    • Insights on disparities in healthcare access based on urban/rural settings, food deserts, and race/ethnicity
  • Mortality Insights: 
    • Derived from non-traditional sources and updated weekly

The data blends also provide a longitudinal view across all settings of care and all populations, reducing potential biases from single-source data. Advanced subgroup analyses enable researchers to identify distinct patient populations with unique treatment responses, fostering personalized care and more effective therapeutics and care delivery models. Furthermore, the data blends support proactive monitoring to identify high-risk populations, reduce adverse events, and facilitate patient assistance programs by addressing financial and logistical challenges.

For more information about the new research-ready datasets, visit https://risk.lexisnexis.com/.

About LexisNexis Risk Solutions
LexisNexis Risk Solutions harnesses the power of data and advanced analytics to provide insights that help businesses and governmental entities reduce risk and improve decisions to benefit people around the globe. We provide data and technology solutions for a wide range of industries including insurance, financial services, healthcare and government. Headquartered in metro Atlanta, Georgia, we have offices throughout the world and are part of RELX (LSE: REL/NYSE: RELX), a global provider of information and analytics for professional and business customers. For more information, please visit www.risk.lexisnexis.com and www.relx.com.

Media Contact: 
Syed Shabbir
Sr. Manager, Corporate Communications
LexisNexis Risk Solutions  
816-572-7709  
syed.shabbir@lexisnexisrisk.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/lexisnexis-risk-solutions-launches-research-ready-healthcare-data-blends-to-expedite-research-302362719.html

SOURCE LexisNexis Risk Solutions

Staff

Recent Posts

Restart Life Receives Aggregate Gross Proceeds of Approximately $590,000 from Warrant Exercises and Loan

Vancouver, British Columbia--(Newsfile Corp. - December 22, 2025) - Restart Life Sciences Corp. (CSE: HEAL)…

12 minutes ago

FlyteHealth to Expand Direct Access to Obesity Management Medication for Employers

NEW CANAAN, Conn., Dec. 22, 2025 /PRNewswire/ -- FlyteHealth, a national leader in integrated cardio-kidney-metabolic care,…

12 minutes ago

10 Days, 10 Ways to Spend FSA (Flexible Spending Account) Funds Before the December 31 Use-It-or-Lose-It Deadline, from FSA Store®

The clock is ticking on 2025 FSA funds, and as the use-it-or-lose-it deadline approaches, FSA…

12 minutes ago

TraceLink Wins 2025 Merit Award — Recognized for Healthcare Innovation for the Third Consecutive Year

TraceLink has been named a winner of the 2025 Merit Awards for Healthcare Innovation, marking…

12 minutes ago

NUCALM CELEBRATES RECORD-BREAKING DECEMBER WITH OVER 2 BILLION MINUTES USED AND LARGEST LIVE EVENT ACTIVATION EVER

Tony Robbins' "Date with Destiny" Event Drives Unprecedented Engagement with NuCalm TechnologyPALM BEACH, Fla., Dec.…

12 minutes ago

Point-of-Care Is Just the Beginning: Doceree 360 Report Maps Three Strategic Imperatives for HCP Engagement Across All Digital Touchpoints

New Annual Report Reveals Opportunity for Pharma Marketers to Reach Physicians Throughout Entire Decision-Making Journey—From Learning…

13 minutes ago